2016 American Transplant Congress

Monday, June 13, 2016

3:30pm-3:42pm

Elevated Intragraft Expression of Innate Immunity and Cell Death-Related Markers Characterizes Deceased Donor Conditions and Is a Risk Factor for Adverse Graft Outcome.

M. Eikmans,¹ J. Yang,¹ G. Haasnoot,¹ C. van Kooten,² M. Mallat,² H. de Fijter,² I. Bajema,³ F. Claas.¹

Concurrent Session: Kidney Immune Monitoring 2  •  Ballroom C

3:30pm-3:42pm

Evaluation of a Risk-Stratified Induction Immunosuppression Protocol Utilizing Low-Dose Antithymocyte Globulin in Renal Transplantation.

A. Diamond, Z. Khawaja, M. Simpson, S.-C. Kung, M. Akoad, J. Pomposelli, E. Pomfret.

Concurrent Session: Kidney: Induction Therapy 1  •  Room 312

3:30pm-3:42pm

Human and Mouse Treg Use Lymphotoxin for Migration Across Lymphatic Endothelium.

C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹

Concurrent Session: Regulatory T Cells: Animal Models  •  Room 309

3:30pm-3:42pm

Impact of Preoperative Body Composition on Outcomes After Living Donor Liver Transplantation.

Y. Hamaguchi, T. Kaido, A. Kobayashi, S. Okumura, S. Yagi, H. Okajima, S. Uemoto.

Concurrent Session: Living Donor Liver Transplantation  •  Room 210

3:30pm-3:42pm

Modification of DC Phenotype and Function via Targeted Porous Silicon Nanoparticles.

S. Stead,¹ S. McInnes,² S. Kireta,³ P. Rose,¹ D. Rojas-Canales,³ S. Jesudason,³ S. Grey,⁴ R. Carroll,³ N. Voelcker,² P. Coates.^1,3

Concurrent Session: Innate Immunity in Rejection and Tolerance: Animal Models  •  Room 313

3:30pm-3:42pm

One Year Post VZV Booster: Still Equal Response in Renal Transplant Recipients Compared to Healthy Persons.

M. Kho,¹ W. Weimar,¹ M. Boer-Verschragen,¹ A. van der Eijk,² N. van Besouw.¹

Concurrent Session: Various Viruses, Vaccines, and SOT  •  Room 306

3:30pm-3:42pm

Superior Waitlist and Equivalent Transplant Outcomes Among Hepatitis C RNA-Positive Patients Who Are Willing to Accept Hepatitis C Seropositive Kidneys.

J. Sageshima,¹ A. de Mattos,² C. Troppmann,¹ C. Santhanakrishnan,¹ J. McVicar,¹ B. Gallay,² M. Gandhi,² M. Alnimri,² R. Perez.¹

Concurrent Session: Kidney Transplantation: Allocation, Discard, and HCV  •  Veterans Auditorium

3:30pm-3:42pm

The Association of Life Expectancy by Resident Zip Code and Kidney Transplant Outcomes – What Is True Baseline Risk?

L. Buccini, D. Goldfarb, E. Poggio, S. Flechner, J. Schold.

Concurrent Session: Novel Predictors of Outcome, Big Data and Technology  •  Room 302

3:42pm-3:54pm

B Cell Signature Profiling in Kidney Transplant Patients on Thymoglobulin.

A. Benitez,¹ T. Milford,² K. Torralba,³ K. Payne,² M. De Vera.¹

Concurrent Session: Kidney: Induction Therapy 1  •  Room 312

3:42pm-3:54pm

Composite Score to Define the Risk of Allograft Loss After Standard-of-Care Treatment of Antibody-Mediated Rejection in Kidney Transplantation.

D. Viglietti,¹ A. Loupy,² J. Duong Van Huyen,² J. Verine,¹ A. Zeevi,³ C. Legendre,² D. Glotz,¹ C. Lefaucheur.¹

Concurrent Session: Identifying Antibodies - Tools of the Trade  •  Ballroom B